The ethics of CYP2D6 testing for patients considering tamoxifen

Por Hartman, Anne-Renee, Helft, Paul
Publicado em 2007

Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells

Por Alli, Elizabeth, Sharma, Vandana B, Hartman, Anne-Renee, Lin, Patrick S, McPherson, Lisa, Ford, James M
Publicado em 2011

Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal...

Por Kurian, Allison W., Hartman, Anne‐Renee, Mills, Meredith A., Ford, James M., Daniel, Bruce L., Plevritis, Sylvia K.
Publicado no Health Expect (2005)

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer

Por Tung, Nadine, Lin, Nancy U., Kidd, John, Allen, Brian A., Singh, Nanda, Wenstrup, Richard J., Hartman, Anne-Renee, Winer, Eric P., Garber, Judy E.
Publicado no J Clin Oncol (2016)

Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients with Suspected Lynch Syndrome

Por Yurgelun, Matthew B., Allen, Brian, Kaldate, Rajesh R., Bowles, Karla R., Judkins, Thaddeus, Kaushik, Praveen, Roa, Benjamin B., Wenstrup, Richard J., Hartman, Anne-Renee, Syngal, Sapna
Publicado no Gastroenterology (2015)

Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma

Por Eguchi, Takashi, Kadota, Kyuichi, Chaft, Jamie, Evans, Brent, Kidd, John, Tan, Kay See, Dycoco, Joe, Kolquist, Kathryn, Davis, Thaylon, Hamilton, Stephanie A., Yager, Kraig, Jones, Joshua T., Travis, William D., Jones, David R., Hartman, Anne-Renee, Adusumilli, Prasad S.
Publicado no Oncotarget (2016)

Validation of a Molecular and Pathological Model for Five-Year Mortality Risk in Patients with Early Stage Lung Adenocarcinoma

Por Bueno, Raphael, Hughes, Elisha, Wagner, Susanne, Gutin, Alexander S., Lanchbury, Jerry S., Zheng, Yifan, Archer, Michael A., Gustafson, Corinne, Jones, Joshua T., Rushton, Kristen, Saam, Jennifer, Kim, Edward, Barberis, Massimo, Wistuba, Ignacio, Wenstrup, Richard J., Wallace, William A., Hartman, Anne-Renee, Harrison, David J.
Publicado no J Thorac Oncol (2015)

BRCA1, BRCA2, PALB2, and CDKN2A Mutations in Familial Pancreatic Cancer (FPC): A PACGENE Study

Por Zhen, David B., Rabe, Kari G., Gallinger, Steven, Syngal, Sapna, Schwartz, Ann G., Goggins, Michael G., Hruban, Ralph H., Cote, Michele L., McWilliams, Robert R., Roberts, Nicholas J., Cannon-Albright, Lisa A., Li, Donghui, Moyes, Kelsey, Wenstrup, Richard J., Hartman, Anne-Renee, Seminara, Daniela, Klein, Alison P., Petersen, Gloria M.
Publicado no Genet Med (2014)

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

Por Isakoff, Steven J., Mayer, Erica L., He, Lei, Traina, Tiffany A., Carey, Lisa A., Krag, Karen J., Rugo, Hope S., Liu, Minetta C., Stearns, Vered, Come, Steven E., Timms, Kirsten M., Hartman, Anne-Renee, Borger, Darrel R., Finkelstein, Dianne M., Garber, Judy E., Ryan, Paula D., Winer, Eric P., Goss, Paul E., Ellisen, Leif W.
Publicado no J Clin Oncol (2015)

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation–Associated Breast Cancer With Assessment of a Tumor-Based M...

Por Telli, Melinda L., Jensen, Kristin C., Vinayak, Shaveta, Kurian, Allison W., Lipson, Jafi A., Flaherty, Patrick J., Timms, Kirsten, Abkevich, Victor, Schackmann, Elizabeth A., Wapnir, Irene L., Carlson, Robert W., Chang, Pei-Jen, Sparano, Joseph A., Head, Bobbie, Goldstein, Lori J., Haley, Barbara, Dakhil, Shaker R., Reid, Julia E., Hartman, Anne-Renee, Manola, Judith, Ford, James M.
Publicado no J Clin Oncol (2015)